Cargando…
K(2P)18.1 translates T cell receptor signals into thymic regulatory T cell development
It remains largely unclear how thymocytes translate relative differences in T cell receptor (TCR) signal strength into distinct developmental programs that drive the cell fate decisions towards conventional (Tconv) or regulatory T cells (Treg). Following TCR activation, intracellular calcium (Ca(2+)...
Autores principales: | Ruck, Tobias, Bock, Stefanie, Pfeuffer, Steffen, Schroeter, Christina B., Cengiz, Derya, Marciniak, Paul, Lindner, Maren, Herrmann, Alexander, Liebmann, Marie, Kovac, Stjepana, Gola, Lukas, Rolfes, Leoni, Pawlitzki, Marc, Opel, Nils, Hahn, Tim, Dannlowski, Udo, Pap, Thomas, Luessi, Felix, Schreiber, Julian A., Wünsch, Bernhard, Kuhlmann, Tanja, Seebohm, Guiscard, Tackenberg, Björn, Seja, Patricia, Döring, Frank, Wischmeyer, Erhard, Chasan, Achmet Imam, Roth, Johannes, Klotz, Luisa, Meyer zu Hörste, Gerd, Wiendl, Heinz, Marschall, Tobias, Floess, Stefan, Huehn, Jochen, Budde, Thomas, Bopp, Tobias, Bittner, Stefan, Meuth, Sven G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547300/ https://www.ncbi.nlm.nih.gov/pubmed/34702947 http://dx.doi.org/10.1038/s41422-021-00580-z |
Ejemplares similares
-
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Rolfes, Leoni, et al.
Publicado: (2020) -
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015–2020
por: Huntemann, Niklas, et al.
Publicado: (2021) -
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosis
por: Pfeuffer, Steffen, et al.
Publicado: (2021) -
Therapeutic Apheresis in Acute Relapsing Multiple Sclerosis: Current Evidence and Unmet Needs—A Systematic Review
por: Rolfes, Leoni, et al.
Publicado: (2019) -
Skin Reactions in Patients With Multiple Sclerosis Receiving Cladribine Treatment
por: Rolfes, Leoni, et al.
Publicado: (2021)